Zinc lozenges
Acetate or gluconate
Moderate
Some good studies, not many repeats
Moderate: Cochrane pooled estimate of −2.4 days but wide interval and low certainty; heterogeneous lozenge formulations.
A 2024 review found colds ended about 2 days sooner when lozenges were started within a day of the first symptoms, which is when your device flags a temperature or heart rate change. The evidence is not very certain.
When your wearable flags an illness onset — temperature up, resting heart rate up — zinc lozenges started within 24 hours may shorten the cold by about two days (Cochrane 2024, low certainty). They do little for prevention and nothing for severity.
Ionic zinc in the throat inhibits rhinovirus replication and binding.
Start at first symptoms/deviation; acetate or gluconate lozenges, ≥75 mg/day total. Never intranasal. Stop when well.
What to buy
- ✓Zinc acetate or gluconate LOZENGES (not tablets)
- ✓13–23 mg per lozenge, dissolve slowly
- ✕Nasal zinc (anosmia)
- ✕Long-term daily high-dose zinc (copper depletion)
- · Metallic taste, nausea. Never intranasal zinc (anosmia). Long-term high dose depletes copper.
As an Amazon Associate, Umbral earns from qualifying purchases. Product data is provided by Amazon and may change; ratings and prices shown are Amazon’s, not Umbral’s. Recommendations are based on the evidence grade and the form used in trials, never on commission.

The formulation with the best cold-duration data.
Buy on AmazonPrefer to compare yourself? This opens Amazon’s full selection for this supplement, filtered to the form we recommend.
See all on AmazonEvery result, next to the line that means no effect
Each diamond is a study's best estimate. The thin line shows how sure the study was: the shorter the line, the more certain the result.
- Cold durationdays · Cochrane 2024−2.37−4.21 … −0.53
Each unit gets its own scale, so numbers are never mixed on one line. When a study gave no range, we leave it blank instead of inventing one.
1 studies over 1 years
The studies
- 1.Zinc for prevention and treatment of the common coldCochrane Database of Systematic Reviews · 2024 · systematic review · 34 experiments · n = 8,526
May shorten colds by ~2 days (MD −2.37, 95% CI −4.21 to −0.53); low-certainty evidence; little effect on prevention or severity.
Umbral is a wellness product, not a medical device. It does not diagnose, treat, cure or prevent any disease. Supplement information is educational; talk to a clinician before starting anything, especially if you are pregnant, under 18, managing a condition or taking medication.
These statements have not been evaluated by the Food and Drug Administration.